Header cover image

Software Healthcare Sector

Results

2168

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2168 companies

NurExone Biologic

Market Cap: CA$59.8m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

NRX

CA$0.59

7D

24.2%

1Y

-26.3%

Medical Developments International

Market Cap: AU$60.3m

Provides emergency medical solutions in Australia, Europe, the United States, and internationally.

MVP

AU$0.54

7D

9.2%

1Y

-15.7%

DocGo

Market Cap: US$43.0m

Operates as a mobile healthcare services company in the United States and the United Kingdom.

DCGO

US$0.38

7D

-46.3%

1Y

-76.7%

Incannex Healthcare

Market Cap: US$42.7m

A clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.

IXHL

US$3.62

7D

9.2%

1Y

-83.7%

Edesa Biotech

Market Cap: US$42.7m

A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.

EDSA

US$4.40

7D

-22.1%

1Y

81.8%

QT Imaging Holdings

Market Cap: US$42.6m

Engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally.

QTI

US$3.31

7D

22.6%

1Y

-52.6%

Werewolf Therapeutics

Market Cap: US$42.5m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

HOWL

US$0.88

7D

117.8%

1Y

-35.5%

Neurothera Labs

Market Cap: CA$58.5m

Engages in the development of a portfolio of drugs based on cannabinoid molecules.

NTLX

CA$0.34

7D

-1.4%

1Y

n/a

Interpace Biosciences

Market Cap: US$42.2m

Provides molecular diagnostic tests and pathology services for evaluating cancer risk in the United States.

IDXG

US$1.43

7D

-15.9%

1Y

68.2%

China Pharma Holdings

Market Cap: US$42.2m

Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.

CPHI

US$0.95

7D

-12.0%

1Y

-33.1%

Elutia

Market Cap: US$42.1m

A commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications.

ELUT

US$0.95

7D

-2.1%

1Y

-60.0%

Milestone Scientific

Market Cap: US$42.0m

A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.

MLSS

US$0.47

7D

-3.1%

1Y

-19.3%

InspireMD

Market Cap: US$41.8m

A medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally.

NSPR

US$0.87

7D

-1.1%

1Y

-63.8%

Aligos Therapeutics

Market Cap: US$41.7m

A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases.

ALGS

US$6.93

7D

5.4%

1Y

-32.1%

Little Green Pharma

Market Cap: AU$58.0m

Produces and sells cannabis-based medicinal products across Australia and Europe.

LGP

AU$0.07

7D

-5.4%

1Y

-46.2%

MedPal AI

Market Cap: UK£30.3m

Operates as a digital health and artificial intelligence company focused on wellness management in United Kingdom.

MPAL

UK£0.037

7D

-2.6%

1Y

-42.3%

Botanix Pharmaceuticals

Market Cap: AU$57.4m

Operates as a commercial dermatology company in Australia and the United States.

BOT

AU$0.021

7D

5.0%

1Y

-86.9%

GoldCoast Resource

Market Cap: CA$56.5m

Engages in the exploration of gold deposits in Ghana.

GCR

CA$0.80

7D

-5.9%

1Y

-30.3%

Ceretas

Market Cap: AU$57.1m

Engages in developing a portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia.

CTS

AU$0.80

7D

8.1%

1Y

n/a

Singular Health Group

Market Cap: AU$57.0m

A medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia.

SHG

AU$0.18

7D

2.9%

1Y

-43.8%

SANUWAVE Health

Market Cap: US$40.6m

Operates as a medical device company in the United States and internationally.

SNWV

US$4.72

7D

-4.8%

1Y

-88.9%

Scilex Holding

Market Cap: US$40.3m

Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

SCLX

US$5.66

7D

-11.6%

1Y

-69.1%

CervoMed

Market Cap: US$39.6m

A clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

CRVO

US$2.63

7D

0.8%

1Y

-72.1%

EUDA Health Holdings

Market Cap: US$39.6m

Engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.

EUDA

US$15.40

7D

6.3%

1Y

-71.2%

Theralase Technologies

Market Cap: CA$54.7m

A clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally.

TLT

CA$0.19

7D

2.7%

1Y

-5.0%

Cell Source

Market Cap: US$39.5m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

CLCS

US$0.65

7D

0%

1Y

58.0%

Ocumetics Technology

Market Cap: CA$54.4m

Engages in research, development, production, and sale of vision enhancement products in Canada.

OTC

CA$0.41

7D

-3.5%

1Y

-69.9%

Growth Stalk Holdings

Market Cap: US$39.2m

Engages in the sowing of the seeds for cultivation and selling of cannabis.

GSTK

US$1.22

7D

0%

1Y

n/a

Compumedics

Market Cap: AU$52.9m

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East.

CMP

AU$0.27

7D

17.8%

1Y

-7.0%

VIP Gloves

Market Cap: AU$55.1m

Engages in the production and trading of nitrile gloves in Malaysia.

VIP

AU$0.07

7D

0%

1Y

n/a

Cryo-Cell International

Market Cap: US$36.8m

Engages in cord blood and cord tissue cryopreservation services in the United States.

CCEL

US$4.39

7D

18.6%

1Y

1.2%

PAVmed

Market Cap: US$36.2m

Engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.

PAVM

US$5.10

7D

-4.2%

1Y

-65.2%

BetterLife Pharma

Market Cap: US$36.0m

A biotechnology company, engages in the development of psychedelic-derived compounds.

BETR.F

US$0.22

7D

8.2%

1Y

248.5%

OneMedNet

Market Cap: US$35.6m

A healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.

ONMD

US$0.59

7D

-3.3%

1Y

-22.7%

MedMira

Market Cap: CA$49.1m

A biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally.

MIR

CA$0.065

7D

8.3%

1Y

-13.3%

Radnostix

Market Cap: US$35.3m

Manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally.

INIS

US$0.059

7D

-12.6%

1Y

-36.2%

Page 28 of 61